Orgenesis Alpha and Beta Analysis
| ORGSDelisted Stock | USD 1.22 0.31 20.26% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Orgenesis. It also helps investors analyze the systematic and unsystematic risks associated with investing in Orgenesis over a specified time horizon. Remember, high Orgenesis' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Orgenesis' market risk premium analysis include:
Beta 4.59 | Alpha (2.03) | Risk 13.72 | Sharpe Ratio (0.29) | Expected Return (3.96) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Orgenesis |
Orgenesis Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Orgenesis market risk premium is the additional return an investor will receive from holding Orgenesis long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Orgenesis. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Orgenesis' performance over market.| α | -2.03 | β | 4.59 |
Orgenesis Fundamentals Vs Peers
Comparing Orgenesis' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Orgenesis' direct or indirect competition across all of the common fundamentals between Orgenesis and the related equities. This way, we can detect undervalued stocks with similar characteristics as Orgenesis or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Orgenesis' fundamental indicators could also be used in its relative valuation, which is a method of valuing Orgenesis by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Orgenesis to competition |
| Fundamentals | Orgenesis | Peer Average |
| Return On Equity | -7.27 | -0.31 |
| Return On Asset | -0.3 | -0.14 |
| Operating Margin | (16.54) % | (5.51) % |
| Current Valuation | 23.01 M | 16.62 B |
| Shares Outstanding | 4.77 M | 571.82 M |
| Shares Owned By Insiders | 21.16 % | 10.09 % |
| Shares Owned By Institutions | 4.54 % | 39.21 % |
Orgenesis Opportunities
Orgenesis Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Orgenesis Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Orgenesis or other otcs. Alpha measures the amount that position in Orgenesis has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Orgenesis Upcoming Company Events
As portrayed in its financial statements, the presentation of Orgenesis' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Orgenesis' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Orgenesis' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Orgenesis. Please utilize our Beneish M Score to check the likelihood of Orgenesis' management manipulating its earnings.
| 19th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Orgenesis
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price. Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Orgenesis OTC Stock
If you are still planning to invest in Orgenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orgenesis' history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |